Illumina, Inc. ILMN is set to release fourth-quarter 2025 results on Feb. 5, after the closing bell. The company posted adjusted earnings per share (EPS) of $1.34 in the last reported quarter, which ...

TL;DR: AMD will maintain its RDNA 3.5 GPU architecture for mainstream and low-end APUs until at least 2029, reserving the advanced RDNA 5 GPU cores for premium Halo-tier SoCs like the Zen 6-based ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Contrary to popular belief, beauty doesn’t have to ...

Rumor mill: If you're a gamer looking forward to the next generation of graphics cards, be prepared for a long wait. With no GeForce RTX 50 Super series, Nvidia isn't expected to release a new ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

New York Post may receive revenue from affiliate and advertising partnerships for sharing this content and/or when you make a purchase. Once I hit middle age, I became ruthless about preserving the ...

Eli Lilly expanded its artificial intelligence drug discovery pact with XtalPi to antibodies. Celltrion in-licensed two innovative autoimmune candidates. China will lift its import ban on Illumina's ...

Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country. The move is a reversal from China’s previous position, which blocked ...

Taiwan-based gene sequencing company Genomics BioSci & Tech has entered a strategic partnership with global sequencing leader Illumina to jointly promote gene sequencing and multi-omics technologies ...

Graphics Cards 'Credible and reliable contacts' claim Nvidia is releasing an RTX 5090-beating GPU around September time this year Graphics Cards Best graphics cards in 2026: I've tested pretty much ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — A year ago, Illumina CEO Jacob Thaysen laid out a plan for the genomics ...